Evidence map›Paper›PMID 34413500›Full record

ArticleNature chemistry2021

A glycan gate controls opening of the SARS-CoV-2 spike protein.

Terra Sztain, Surl-Hee Ahn, Anthony T Bogetti, Lorenzo Casalino, Jory A Goldsmith, Evan Seitz, Ryan S McCool, Fiona L Kearns, Francisco Acosta-Reyes, Suvrajit Maji and 7 more

Abstract read
In one paragraph

Article in Nature chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 222 papers.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

222 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Glycans Modulate the Adsorption of RBD Glycoproteins on Polarizable Surfaces.Journal of chemical information and modeling · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Terra Sztain *Department of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA.
Surl-Hee Ahn *Department of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-3422-805X
Anthony T BogettiDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Lorenzo CasalinoDepartment of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3581-1148
Jory A GoldsmithDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Evan SeitzDepartment of Biological Sciences, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0001-6844-2444
Ryan S McCoolDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Fiona L KearnsDepartment of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA.
Francisco Acosta-ReyesDepartment of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY, USA.
Suvrajit MajiDepartment of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-5547-1975
Ghoncheh MashayekhiDepartment of Physics, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
J Andrew McCammonDepartment of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3065-1456
Abbas OurmazdDepartment of Physics, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0001-9946-3889
Joachim FrankDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Jason S McLellanDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Lillian T ChongDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA. ltchong@pitt.edu.ORCID http://orcid.org/0000-0002-0590-483X
Rommie E AmaroDepartment of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA. ramaro@ucsd.edu.ORCID http://orcid.org/0000-0002-9275-9553

Funding

THEORY OF BIOMOLECULAR DIFFUSIONR01GM031749 · NIGMS · UNIVERSITY OF HOUSTON · PI HUBER, GARY ALEXANDER, MCCAMMON, JAMES ANDREW · 1985 to 2022
$7.8M
STRUCTURE ANALYSIS OF MACROMOLECULAR ASSEMBLIESR01GM029169 · NIGMS · WADSWORTH CENTER · PI FRANK, JOACHIM · 1985 to 2019
$6.1M
WESTPA: A high-performance framework for simulating at the frontiers of biologyR01GM115805 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LILLIAN T CHONG · 2015 to 2026
$4.0M
Structural Studies of Macromolecular Assemblies Using Cryo-EMR35GM139453 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FRANK, JOACHIM · 2021 to 2025
$3.9M
Structure, Function and Antigenicity of Coronavirus Spike ProteinsR01AI127521 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI MCLELLAN, JASON SCOTT, WARD, ANDREW BARRETT · 2017 to 2021
$3.1M
A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS (Equipment Supplement)R01GM132826 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2019 to 2022
$1.3M
National Science Foundation (NSF) CHE-1807301National Science Foundation (NSF) GRFP DGE-1650112National Science Foundation (NSF) MCB-2032054NIAID NIH HHS R01 AI127521NIGMS NIH HHS R01 GM029169NIGMS NIH HHS R01 GM031749NIGMS NIH HHS R01 GM115805NIGMS NIH HHS R01 GM132826NIGMS NIH HHS R35 GM139453U.S. Department of Health & Human Services | National Institutes of Health (NIH) GM132826U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (OER) R01 GM31749
6 · The paper itself

Abstract

SARS-CoV-2 infection is controlled by the opening of the spike protein receptor binding domain (RBD), which transitions from a glycan-shielded 'down' to an exposed 'up' state to bind the human angiotensin-converting enzyme 2 receptor and infect cells. While snapshots of the 'up' and 'down' states have been obtained by cryo-electron microscopy and cryo-electron tomagraphy, details of the RBD-opening transition evade experimental characterization. Here over 130 µs of weighted ensemble simulations of the fully glycosylated spike ectodomain allow us to characterize more than 300 continuous, kinetically unbiased RBD-opening pathways. Together with ManifoldEM analysis of cryo-electron microscopy data and biolayer interferometry experiments, we reveal a gating role for the N-glycan at position N343, which facilitates RBD opening. Residues D405, R408 and D427 also participate. The atomic-level characterization of the glycosylated spike activation mechanism provided herein represents a landmark study for ensemble pathway simulations and offers a foundation for understanding the fundamental mechanisms of SARS-CoV-2 viral entry and infection.

Indexed as

Cryoelectron MicroscopyHumansMolecular Dynamics SimulationPolysaccharidesSpike Glycoprotein, CoronavirusPolysaccharidesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID34413500
PMCPMC8488004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.